HP
OMGA

Harbourvest Partners’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Harbourvest Partners’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,512,110
Closed -$2.62M – 22
2024
Q4 		$2.62M Hold
3,512,110
– – 1.29% 9
2024
Q3 		$4.28M Hold
3,512,110
– – 2.23% 6
2024
Q2 		$7.27M Hold
3,512,110
– – 3.87% 5
2024
Q1 		$12.8M Hold
3,512,110
– – 5.85% 4
2023
Q4 		$10.6M Hold
3,512,110
– – 3.54% 7
2023
Q3 		$7.55M Hold
3,512,110
– – 2.56% 6
2023
Q2 		$19.7M Hold
3,512,110
– – 5.59% 6
2023
Q1 		$21.2M Buy
3,512,110
+865,051
+33% +$6.02M 7.13% 6
2022
Q4 		$15.1M Hold
2,647,059
– – 5.06% 7
2022
Q3 		$14.3M Hold
2,647,059
– – 4.69% 7
2022
Q2 		$10.1M Hold
2,647,059
– – 3.3% 7
2022
Q1 		$16.5M Hold
2,647,059
– – 3.37% 8
2021
Q4 		$30M Hold
2,647,059
– – 3.83% 6
2021
Q3 		$49.9M Buy
+2,647,059
New +$50.8M 4.69% 4

Other funds holding OMGA

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Harbourvest Partners's OMGA Position: Q1 2025 in Review

Harbourvest Partners sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 3,512,110 shares — an estimated $2.62M sold.

Harbourvest Partners first reported a position in OMGA in Q3 2021 and held it in 14 quarters. The position peaked at $49.9M in Q3 2021. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

  • Harbourvest Partners reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Harbourvest Partners sold 3,512,110 Omega Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $2.62M.
  • Harbourvest Partners first reported a position in Omega Therapeutics, Inc. Common Stock in Q3 2021 and held it in 14 quarters.
  • Harbourvest Partners's Omega Therapeutics, Inc. Common Stock position peaked at $49.9M in Q3 2021.
  • 4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Harbourvest Partners's 13F filing for Q1 2025, filed 15 May 2025.